Global Collaboration in Pediatric Drug Development and Formulation: Toward Better and Safe, and Appropriate Formulation for Children

Dear Colleagues,

For pediatric patients, the formulations designed for and tested on adults lead to incorrect dosing, poor acceptance, complicated administration practice (i.e., pediatric compounding), and therapeutic failure or adverse events. Enhanced awareness of these issues, children’s needs, and evolving regulatory expectations may accelerate the development of age-appropriate pediatric formulation. Research and understanding of the desired medicinal products for the pediatric population all over the world are important for regulators, academics, pharmaceutical industries, and clinical settings. International collaboration on appropriate drug development is also a key area of rapid innovation of pediatric formulation. The development of harmonized guidelines for pediatric drug development also activates pediatric drug development and leads to a better healthcare environment for pediatric patients and their care-givers. This Special Issue aims to review and integrate the knowledge and ongoing efforts in the field of pediatric development.

We welcome original research, reviews, opinion papers, editorials, or short communications on the following topics:

• Pediatric drug development;
• Acceptability study in pediatrics;
• Excipients use in pediatric formulations;
• Age-appropriate drug development;
• Issues and challenges in pediatric compounding
• International collaboration on regulation for pediatric drug development
• Advanced technology for pediatric formulation

Dr. Jumpei Saito
Dr. Akimasa Yamatani
Dr. Takehisa Hanawa
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Children is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.